HLA-DR expression at diagnosis is not predictive of relapse risk post allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia: a report from the Children’s Oncology Group | Synapse
March 28, 2026Open Access
HLA-DR expression at diagnosis is not predictive of relapse risk post allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia: a report from the Children’s Oncology Group
Key Points
The study examines whether HLA-DR expression at diagnosis can predict relapse risk after stem cell transplantation in pediatric acute myeloid leukemia.
Analysis of HLA-DR expression at the time of diagnosis
Follow-up data post allogeneic hematopoietic stem cell transplantation
Data sourced from the Children's Oncology Group
HLA-DR expression at diagnosis does not correlate with relapse risk
No significant predictive value was found for HLA-DR expression
The findings suggest alternative factors may influence relapse risk